Managing acute chest syndrome of sickle cell disease in an African setting

dc.contributor.author	Fawibe, AE
dc.date.accessioned	2023-06-30T10:13:45Z
dc.date.available	2023-06-30T10:13:45Z
dc.date.issued	2008-03
dc.description.abstract	Despite the fact that acute chest syndrome contributes immensely to morbidity and mortality in patients with sickle cell anaemia, its exact aetiopathogenesis is very complex and not yet well understood. Therefore, a high index of suspicion is needed in its diagnosis, and appropriate treatment should be commenced as soon as possible to prevent lethal complications of this condition, especially in Nigeria where appropriate diagnostic and therapeutic facilities may not be readily available. This is very important, as it may even develop on hospital admission. There is a need to further investigate preventive measures such as the use of hydroxyurea and the newly introduced Nicosan, especially in those people with recurrent disease, in order to reduce both short- and long-term complications of this syndrome among sickle cell patients in Nigeria.	en_US
dc.identifier.other	https://doi.org/10.1016/j.trstmh.2008.03.018
dc.identifier.uri	https://uilspace.unilorin.edu.ng/handle/20.500.12484/11394
dc.language.iso	en	en_US
dc.publisher	Royal Society of Tropical Medicine and Hygiene, UK	en_US
dc.subject	Acute chest syndrome, Sickle cell anaemia, Hydroxyurea, Analgesics, Nigeria, Africa	en_US
dc.title	Managing acute chest syndrome of sickle cell disease in an African setting	en_US
dc.type	Article	en_US

Files

Now showing 1 - 1 of 1

Name:: Managing acute chest syndrome of sickle disease in an African setting.pdf
Size:: 164.76 KB
Format:: Adobe Portable Document Format
Description:: main article